CHRM3 and synovial sarcoma: The correlation between salivary flow rate and salivary EGF output was evaluated in 13 SS patients, excluding those under medical treatment that might have affected salivary flow rate (e.g., muscarinic M3 receptor agonist, corticosteroids, and immunosuppressants).